• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Psychedelic Titans with Maurice Bright of Psilo Academy, Figarelli House Corp. (dba Psilocybin Academy™)

Microdose by Microdose
September 28, 2021
in Psychedelic Titans
Reading Time: 2 mins read
A A
Psychedelic Titans with Maurice Bright of Psilo Academy, Figarelli House Corp. (dba Psilocybin Academy™)

This week’s Psychedelic Titan is Maurice Bright, Chancellor and Head of Operations for Psilo Academy, Figarelli House Corp. (dba Psilocybin Academy™).

What’s this article series about? Psychedelic Titans is a get-to-know-you-style blog series interviewing some of the psychedelic industry’s most influential and impactful individuals.

When did you first become involved in the psychedelic industry and why?

I spent 2 years in Corporate Cannabis as a Head of I.T. prior and felt psychedelics were going to be the next alt medicine industry to catch fire, so it was a relatively easy choice to migrate over.

Do you, or have you taken, psychedelic substances?

Yes, currently indulge in psilocybin and LSD. Psilocybin more so than LSD 😉

[bsa_pro_ad_space id=2]
ADVERTISEMENT

What’s your favourite psychedelic compound?

Psilocybin — it boosts the efficiency of my critical thinking.

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

Do your parents/family members know what you’re doing?

Yes.

Have you had an experience with mental health/chronic pain?

Order Lasix Today

No.

What’s your vision of the industry in 20 years?

I envision the industry will be similar to cannabis but with far more Institutional acceptance and impact on the mental health industry as a whole.

What are your biggest worries for the industry?

Governments not understanding the conducive results psychedelics can have on society and hamstringing laws in favor of these drugs.

Who are your heroes?

My mum.

If you could create a psychedelic to do anything you wanted, what would it do?

Hit me with the same effects as LSD and a trip time aligned with the duration of a cannabis high.

 

We’d like to thank for being a part of the Psychedelic Titans series. Stay tuned for more profiles on leaders in the psychedelic industry.

Would you like to participate in this series? Fill out this form and we’ll follow up with a review of your application.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
Psychedelic Groundbreakers: Integration Communications

Psychedelic Groundbreakers: Integration Communications

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.